NRRC Summer ‘02 Workshop Proposal Re-use November 30, 2001 MITRE Marc Light and Abraham Ittycheriah.

Slides:



Advertisements
Similar presentations
Knowledge-based Information Retrieval: A Work in Progress Knowledge-based Systems Research Group, University of Texas at Austin.
Advertisements

Copyright © 2002 Cycorp Introduction Fundamental Expression Types Top Level Collections Time and Dates Spatial Properties and Relations Event Types Information.
NRRC Summer ‘02 Workshop Proposal Temporal December 5, 2001 MITRE James Pustejovsky, Brandeis with input from: James Allan, UMASS Inderjeet Mani, MITRE.
Anthrax. References What You Need to Know Frequently Asked Questions
A Corpus for Cross- Document Co-Reference D. Day 1, J. Hitzeman 1, M. Wick 2, K. Crouch 1 and M. Poesio 3 1 The MITRE Corporation 2 University of Massachusetts,
BIOLOGICAL AGENTS  CDC has prioritized them in Lists A - C  A List:  Easily transmitted/disseminated  High mortality rate  Potential for public panic.
The IND and Clinical Trial Management Frances Richmond Director International Center for Clinical Trials.
The Division of Monoclonal Antibodies Kathleen A. Clouse, Ph.D., Director CTGTAC - July 26, 2007.
1 Pathfinder Chlamydia Screening Pilot Presented by Rebecca Adeojo on behalf of : Danielle Mercey (1) Tina Sharp (2) Jill Martin (3) Julie Hamner (4) 1)
CPT Review of Drug Administration Services AMA Presentation.
ANTHRAX By: Justin Tursellino. Anthrax is a…. Anthrax is an infection caused by a bacterium, Bacillus anthracis. The infection can take three forms depending.
Mildred Using Plants: The Medicinal Value of Plants
Ang Sun Ralph Grishman Wei Xu Bonan Min November 15, 2011 TAC 2011 Workshop Gaithersburg, Maryland USA.
Document Number Here © 2006 The MITRE Corporation. All rights reserved. Holds and Diversions June 22, 2004.
Systematic Approach for Answering a Drug Information Request:
Problems and Situations in Searching the Literature.
Drug Discovery Process
Is this Research? Exempt? Expedited?
Stages of drug development
Paula Peyrani, MD Medical/Project Director, HIV Program at the 550 Clinic Assistant Director, Research Design and Development Clinical and Translational.
Copyright Medical Group Management Association. All rights reserved. Name, credentials Organization Date Preparing Your Office Practice for Disaster.
Grade 7 MSM II Extended Session April 26, :30-11:00 Rooms 604 & 605.
Probabilistic Model for Definitional Question Answering Kyoung-Soo Han, Young-In Song, and Hae-Chang Rim Korea University SIGIR 2006.
Anthrax Briefing. Anthrax Briefing What is anthrax? Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis.
SNOMED CT Denise Downs Knowledge Management & Education Lead Data Standards, Technology Office Department of Health Informatics Directorate.
Anthrax Hunter JM Sept.30/2012. Bacillus Anthracis Commonly known as ‘Anthrax’, bacillus anthracis is extremely lethal. There are very few cures for the.
39187n n n
IECM Briefing: XML Community of Practice Betsy Fanning AIIM.
PHARMACOVIGILANCE AND CLINICAL TRIALS DIVISION 20 August 2015 Victoria Falls Protecting Your Right to Quality Medicines and Medical Devices.
From the Lab to Market Unit 3.04 Understanding Biotechnology research & Development.
AnswerBus Question Answering System Zhiping Zheng School of Information, University of Michigan HLT 2002.
Applied Epidemiology Sharla Smith. Discussion Assignments How to complete a discussion assignment –Read the chapters –Evaluate the question –Be very specific.
AQUAINT Testbed Activity John Burger, Marc Light, Scott Mardis, Alex Morgan The MITRE Corporation © 2002, The MITRE Corporation.
By: Brittany Horan Large, aerobic, gram-positive, non- motile, encapsulated, chain forming, rod shaped that form oval spores. It is a bacterium of the.
Approved: 9 Jun DoD Leader’s Briefing: Force Health Protection Against Anthrax.
Component 6 - Health Management Information Systems Unit 1-2 What is Health Informatics?
Definitions. Clinical pharmacy is the branch of Pharmacy where pharmacists provide patient care that optimizes the use of medication and promotes health,
Anthrax Jennifer Park. Scientific Name: Bacillus anthracis Kingdom: Bacteria, Phylum: Firmicutes Class: Bacilli, Order: Bacillales, Family: Bacillaceae.
Inside Clinical Trials ® ALL RIGHTS RESERVED. What is a clinical trial? ALL RIGHTS RESERVED.
AQUAINT IBM PIQUANT ARDACYCORP Subcontractor: IBM Question Answering Update piQuAnt ARDA/AQUAINT December 2002 Workshop This work was supported in part.
The Killer Spore Anthrax Sara Bornstein. Bacillus Anthracis Anthrax is a bacteria, with a few specific characteristics: Anthrax has a thick outer capsule,
1 Question Answering and Logistics. 2 Class Logistics  Comments on proposals will be returned next week and may be available as early as Monday  Look.
Chapter 32 Epidemiology the Core Understanding of Public Health.
NRRC Summer ‘02 Mini-Workshop Report Reuse June 6th, 2002 MITRE Abraham Ittycheriah, Andy Latto, Marc Light, Nancy McCracken.
NRRC Summer ‘02 Workshop Proposal: Habitability December 5, 2001 MITRE Christy Doran, MITRE Joe Marks, MERL
The Case of the Mystery Disease.  Public Health Official  Physician  Laboratory Scientist  Field Researcher.
Clinical Trials.
Presidents Report Bob Reinovsky 30 July Standards Strength of IEEE Base of Technical Expertise Generally recognized as a-political Currently strong.
Workforce Development Domain Task Force
ECE362 – Principles of Design
Vitamins, herbs, and nutritional supplements
Biological agents that might be used as weapons of Bioterrorism
CPMGT 300 STUDY Lessons in Excellence--cpmgt300study.com.
CPMGT 300 Education for Service/snaptutorial.com.
E. Svensson, J. Millet, A. Lindqvist, M. Olsson, M. Ridell, N. Rastogi 
iECM Briefing: XML Community of Practice
GREEN LIGHT Recommendations for mentorship and/or collaboration
M. Giannella, B. Pinilla, J. A. Capdevila, J. Martínez Alarcón, P
R. Cantón  Clinical Microbiology and Infection 
Assessment Workshop Title of the Project (date)
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Epidemiological investigation of a case of nosocomial Legionnaires' disease in Taiwan: implications for routine environmental surveillance  S.T. Chien,
N. Wurtz, M.P. Grobusch, D. Raoult  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the pharmaceutical perspective
Rachel Sparks, William W. Lau, John S. Tsang  Immunity 
Community-acquired pneumonia: epidemiologic and clinical consideration
Antimicrobial drug development – the past, the present, and the future
Introduction to Basic Research Methods
Chinese Fibromyalgia Market is expected to grow at a CAGR of 18.7% during the forecast period PREPARED BY Market Research Future (Part of Wantstats.
Presentation transcript:

NRRC Summer ‘02 Workshop Proposal Re-use November 30, 2001 MITRE Marc Light and Abraham Ittycheriah

Page 2 Copyright © 2001 The MITRE Corporation. All rights reserved. Problem A QA system should accumulate information derived in the process of answering questions. Such information should enable the system to better answer future questions.  What information should be stored?  How should it be stored?  How will it be used?

Page 3 Copyright © 2001 The MITRE Corporation. All rights reserved. Motivating Examples  What are some medicines that treat anthrax? The FDA has approved Cipro (ciprofloxacin), tetracyclines, including doxycycline, and penicillins to treat anthrax.  What are some of the side effects of anthrax medicines? The Physician’s Desk Reference reports that of 2,799 patients who took Cipro during clinical investigations, 16.5 percent had adverse reactions that were possibly or probably related to the drug. The most frequently reported reactions; diarrhea, vomiting, abdominal discomfort, headache, ….  Who manufactures anthrax medicine? -Cipro is produced in the U.S. by the german pharmaceutical company Bayer AG. Text from

Page 4 Copyright © 2001 The MITRE Corporation. All rights reserved. Motivating Examples  What is anthrax? Anthrax is an infectious disease caused by the spore-forming bacteria called Bacillus anthracis. Infection in humans most often involves the skin (cutaneous anthrax)  Where can anthrax be obtained? Los Alamos National labs has stored samples of the B. anthracis spores.  Which countries have anthrax cultures? In this NOVA episode, they mentioned the American Type Culture Collection (ATCC), which had made the embarrassing mistake of selling B. anthracis cultures to Iraq.

Page 5 Copyright © 2001 The MITRE Corporation. All rights reserved. Approach  Collect questions and answers such as the previous examples from a small number of domains (e.g., epidemiology, terrorism, nuclear proliferation, etc.)  Find and Classify different types of possible re-use  Build a system that performs subset of the re-use types in a small number of domains  Evaluate by comparing system performance (e.g., MRR and task completion time) when “reuse” is turned off vs. on

Page 6 Copyright © 2001 The MITRE Corporation. All rights reserved. QA System Information Retrieval Question Analysis Documents Question Answer candidate search Answer candidate ranking Answer candidates Ranked answer candidates Answer construction answer strings Re-Use KB Structured representation for question and documents, i.e., entity typing (coarse- and fine- grained), pred-arg structure, geo-temporal tagging, coreference, predicate normalization, etc. Static KB (WordNet, Cyc, etc.)

Page 7 Copyright © 2001 The MITRE Corporation. All rights reserved. Domain and Data sets 5 problems from one domain each requiring questions Examples: -Characterize the victims of the Anthrax attack.  Time, location, name, age, occupation, type of infection, and eventual-outcome for each reported incident. -Characterize the biological weapon  Location, quality of spores, contents of letter, wording of letter, postmark of letter, etc.  Characterize the possible sources of such a weapon  Location, owner, type of spore produced

Page 8 Copyright © 2001 The MITRE Corporation. All rights reserved. Proposed Team Membership  Team Co-leads: -Marc Light (MITRE) and Abraham Ittycheriah (IBM)  Full time members -Nancy McCrackey (Syracuse Uni) -A member of the MetaCarta R&D team and/or A member of the Cycorp R&D team  Part time members -Benjamin Wellner (MITRE) -William Woods (Sun)  Visiting participants - John Frank (MetaCarta) - Liz Liddy (Syracuse Uni) -Salim Roukus (IBM)  Guest speakers -Eugene Charniak (Brown Uni) -Dragomir Radev (UofMich) -Stephen Kosslyn (Harvard)

Page 9 Copyright © 2001 The MITRE Corporation. All rights reserved. Work Plan  Prior to workshop begin: -Pick domains and collect questions and documents -Develop problems for development and testing -Develop QA system based on IBM, Syracuse, and MITRE systems and components  First 4 weeks (May) -Data analysis wrt re-use -Implement initial re-use modules -Initial evaluation  Interim (June and July) -Refine data analysis and implementation  Second 4 weeks (August) -Experiment and evaluate

Page 10 Copyright © 2001 The MITRE Corporation. All rights reserved. Impact  A better understanding of the types of re-use  A system that exemplifies re-use  A system that grows a knowledge base as it answers questions Total Budget: 411k staff is 341k of total